These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38142631)

  • 1. Hair color, family history of melanoma, and the risk of Parkinson's disease: An analysis update.
    Flores-Torres MH; Bjornevik K; Zhang X; Gao X; Hung AY; Schwarzschild MA; Chen X; Ascherio A
    Parkinsonism Relat Disord; 2024 Feb; 119():105965. PubMed ID: 38142631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of hair color and Parkinson's disease risk.
    Gao X; Simon KC; Han J; Schwarzschild MA; Ascherio A
    Ann Neurol; 2009 Jan; 65(1):76-82. PubMed ID: 19194882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family history of melanoma and Parkinson disease risk.
    Gao X; Simon KC; Han J; Schwarzschild MA; Ascherio A
    Neurology; 2009 Oct; 73(16):1286-91. PubMed ID: 19841380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The melanocortin 1 receptor (Mc1r) variants do not account for the co-occurrence of Parkinson's disease and malignant melanoma.
    Elincx-Benizri S; Inzelberg R; Greenbaum L; Cohen OS; Yahalom G; Laitman Y; Djaldetti R; Orlev Y; Scope A; Azizi E; Friedman E; Hassin-Baer S
    J Mol Neurosci; 2014 Dec; 54(4):820-5. PubMed ID: 25284244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson's Disease and Asymptomatic Carriers of Related Genes: A Brief Report.
    Koros C; Simitsi AM; Bougea A; Papagiannakis N; Antonelou R; Pachi I; Angelopoulou E; Prentakis A; Zachou A; Chrysovitsanou C; Beratis I; Fragkiadaki S; Kontaxopoulou D; Eftymiopoulou E; Stanitsa E; Potagas C; Papageorgiou SG; Karavasilis E; Velonakis G; Prassopoulos V; Geronicola-Trapali X; Stefanis L
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629650
    [No Abstract]   [Full Text] [Related]  

  • 6. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.
    Kennedy C; ter Huurne J; Berkhout M; Gruis N; Bastiaens M; Bergman W; Willemze R; Bavinck JN
    J Invest Dermatol; 2001 Aug; 117(2):294-300. PubMed ID: 11511307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Evidence for a Causal Relationship Between Cancers and Parkinson's Disease.
    Senkevich K; Bandres-Ciga S; Yu E; Liyanage UE; ; Noyce AJ; Gan-Or Z
    J Parkinsons Dis; 2021; 11(2):801-809. PubMed ID: 33646179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigmentation as a clue to understanding Parkinson's disease and melanoma.
    Herrero Hernández E
    Ann Neurol; 2009 Jun; 65(6):759; author reply 759. PubMed ID: 19557863
    [No Abstract]   [Full Text] [Related]  

  • 9. The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.
    Tell-Marti G; Puig-Butille JA; Potrony M; Badenas C; Milà M; Malvehy J; Martí MJ; Ezquerra M; Fernández-Santiago R; Puig S
    Ann Neurol; 2015 May; 77(5):889-94. PubMed ID: 25631192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease.
    Dong J; Gao J; Nalls M; Gao X; Huang X; Han J; Singleton AB; Chen H;
    Neurobiol Aging; 2014 Jun; 35(6):1512.e5-1512.e10. PubMed ID: 24439955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies.
    Herrero Hernández E
    Med Hypotheses; 2009 Mar; 72(3):280-4. PubMed ID: 19027242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MC1R variants, melanoma and red hair color phenotype: a meta-analysis.
    Raimondi S; Sera F; Gandini S; Iodice S; Caini S; Maisonneuve P; Fargnoli MC
    Int J Cancer; 2008 Jun; 122(12):2753-60. PubMed ID: 18366057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive factors, hormone use, and incidence of melanoma in a cohort of US Radiologic Technologists.
    Mai JZ; Zhang R; Sargen MR; Little MP; Alexander BH; Tucker MA; Kitahara CM; Cahoon EK
    Hum Reprod; 2022 May; 37(5):1059-1068. PubMed ID: 35174864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial.
    Constantinescu R; Elm J; Auinger P; Sharma S; Augustine EF; Khadim L; Kieburtz K;
    Mov Disord; 2014 Feb; 29(2):263-5. PubMed ID: 24323565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
    Zanetti R; Loria D; Rosso S
    Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical signs of Parkinson's disease: A possible association of Parkinson's disease with skin and hair features.
    Jucevičiūtė N; Banaitytė I; Vaitkus A; Balnytė R
    Med Hypotheses; 2019 Jun; 127():100-104. PubMed ID: 31088630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the relationship between Parkinson disease and melanoma.
    Liu R; Gao X; Lu Y; Chen H
    Neurology; 2011 Jun; 76(23):2002-9. PubMed ID: 21646627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study.
    Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G
    Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping genetic architecture between Parkinson disease and melanoma.
    Dube U; Ibanez L; Budde JP; Benitez BA; Davis AA; Harari O; Iles MM; Law MH; Brown KM; ; ; Cruchaga C
    Acta Neuropathol; 2020 Feb; 139(2):347-364. PubMed ID: 31845298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.